Diabetes, autoimmunity, and arteriosclerosisVAUGHIN, M; VIRELLA, G; LOPES-VIRELLA, M. F et al.Clinical immunology and immunopathology (Print). 1989, Vol 52, Num 3, pp 414-420, issn 0090-1229Article

Oxidized LDL stimulates matrix metalloproteinase-1 expression in human vascular endothelial cellsYAN HUANG; MIRONOVA, M; LOPES-VIRELLA, M. F et al.Arteriosclerosis, thrombosis, and vascular biology. 1999, Vol 19, Num 11, pp 2640-2647, issn 1079-5642Article

Metabolism by human endothelial cells of very low density lipoprotein subfractions isolated from type 1(insulin-dependent) diabetic patientsKLEIN, R. L; LOPES-VIRELLA, M. F.Diabetologia (Berlin). 1993, Vol 36, Num 3, pp 258-264, issn 0012-186XArticle

Isolation and characterization of human antioxidized LDL autoantibodiesMIRONOVA, M; VIRELLA, G; LOPES-VIRELLA, M. F et al.Arteriosclerosis, thrombosis, and vascular biology. 1996, Vol 16, Num 2, pp 222-229, issn 1079-5642Article

Influence of glycemic control on interaction of very-low- and low-density lipoproteins isolated from type I diabetic patients with human monocyte-derived macrophagesKLEIN, R. L; WOHLTMANN, H. J; LOPES-VIRELLA, M. F et al.Diabetes (New York, NY). 1992, Vol 41, Num 10, pp 1301-1307, issn 0012-1797Article

Modification of lipoproteins in diabetesLOPES-VIRELLA, M. F; KLEIN, R. L; VIRELLA, G et al.Diabetes/metabolism reviews. 1996, Vol 12, Num 1, pp 69-90, issn 0742-4221Article

Metabolism of very low- and low-density lipoproteins isolated from normolipidaemic type 2 (non-insulin-dependent) diabetic patients by human monocyte-derived macrophagesKLEIN, R. L; LYONS, T. J; LOPES-VIRELLA, M. F et al.Diabetologia (Berlin). 1990, Vol 33, Num 5, pp 299-305, issn 0012-186X, 7 p.Article

Interaction of very-low-density lipoprotein isolated from type I (insulin-dependent) diabetic subjects with human monocyte-derived macrophagesKLEIN, R. L; LYONS, T. J; LOPES-VIRELLA, M. F et al.Metabolism, clinical and experimental. 1989, Vol 38, Num 11, pp 1108-1114, issn 0026-0495Article

Isolation, characterization, and metabolism of the glycated and nonglycated subfractions of low-density lipoproteins isolated from type I diabetic patients and nondiabetic subjectsKLEIN, R. L; LAIMINS, M; LOPES-VIRELLA, M. F et al.Diabetes (New York, NY). 1995, Vol 44, Num 9, pp 1093-1098, issn 0012-1797Article

Erythrocyte-bound low-density lipoprotein immune complexes lead to cholesteryl ester accumulation in human monocyte-derived macrophagesGISINGER, C; VIRELLA, G. T; LOPES-VIRELLA, M. F et al.Clinical immunology and immunopathology (Print). 1991, Vol 59, Num 1, pp 37-52, issn 0090-1229, 16 p.Article

Immune mechanisms of atherosclerosis in diabetes mellitusLOPES-VIRELLA, M. F; VIRELLA, G.Diabetes (New York, NY). 1992, Vol 41, pp 86-91, issn 0012-1797, SUP2Conference Paper

Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes: a possible mechanism of foam cell formationGRIFFITH, R. L; VIRELLA, G. T; STEVENSON, H. C et al.The Journal of experimental medicine. 1988, Vol 168, Num 3, pp 1041-1059, issn 0022-1007Article

Oxidized LDL-containing immune complexes induce Fc gamma receptor I-mediated mitogen-activated protein kinase activation in THP-1 macrophagesYAN HUANG; JAFFA, A; KOSKINEN, S et al.Arteriosclerosis, thrombosis, and vascular biology. 1999, Vol 19, Num 7, pp 1600-1607, issn 1079-5642Article

Release of platelet plasminogen activator inhibitor 1 in whole blood is increased in patients with type II diabetesJOKI, R; KLEIN, R. L; LOPES-VIRELLA, M. F et al.Diabetes care. 1995, Vol 18, Num 8, pp 1150-1155, issn 0149-5992Article

Enhanced uptake and impaired intracellular metabolism of low density lipoprotein complexed with anti-low density lipoprotein antibodiesLOPES-VIRELLA, M. F; GRIFFITH, R. L; SHUNK, K. A et al.Arteriosclerosis and thrombosis. 1991, Vol 11, Num 5, pp 1356-1367Article

Oxidized LDL-anti-oxidized LDL immune complexes and diabetic nephropathyATCHLEY, D. H; LOPES-VIRELLA, M. F; ZHENG, D et al.Diabetologia (Berlin). 2002, Vol 45, Num 11, pp 1562-1571, issn 0012-186X, 10 p.Article

Lipoproteins and immune responses in the vascular wall and thier contribution to atherosclerosis in diabetesLOPES-VIRELLA, M. F; VIRELLA, G.Metabolism, clinical and experimental. 1992, Vol 41, Num 5, pp 11-15, issn 0026-0495, SUP1Conference Paper

Lipoprotein-immune complexes and diabetic vascular complicationsGISINGER, C; LOPES-VIRELLA, M. F.Diabetes (New York, NY). 1992, Vol 41, pp 92-96, issn 0012-1797, SUP2Conference Paper

Proceedings/Workshop on insulin and atherogenesis, Charleston SC, May 19-20, 1984COLWELL, J. A; LOPES-VIRELLA, M. F; MAYFIELD, R. K et al.Metabolism, clinical and experimental. 1985, Vol 34, Num 12, pp 1-91, issn 0026-0495Conference Proceedings

Antibodies to oxidized LDL predict coronary artery disease in type 1 diabetes : A nested case-control study from the Pittsburgh epidemiology of diabetes complications studyORCHARD, T. J; VIRELLA, G; FORREST, K. Y.-Z et al.Diabetes (New York, NY). 1999, Vol 48, Num 7, pp 1454-1458, issn 0012-1797Article

The uptake of LDL-IC by human macrophages : Predominant involvement of the FcγRI receptorLOPES-VIRELLA, M. F; BINZAFAR, N; RACKLEY, S et al.Atherosclerosis. 1997, Vol 135, Num 2, pp 161-170, issn 0021-9150Article

Stimulation of cholesteryl ester synthesis in human monocyte-derived macrophages by low-density lipoproteins from Type 1 (insulin-dependent) diabetic patients: the influence of non-enzymatic glycosylation of low-density lipoproteinsLYONS, T. J; KLEIN, R. L; BAYNES, J. W et al.Diabetologia (Berlin). 1987, Vol 30, Num 12, pp 916-923, issn 0012-186XArticle

Cytokines, modified lipoproteins, and arteriosclerosis in diabetesLOPES-VIRELLA, M. F; VIRELLA, G.Diabetes (New York, NY). 1996, Vol 45, pp S40-S44, issn 0012-1797, SUP3Conference Paper

Activation of human monocyte-derived macrophages by immune complexes containing low-density lipoproteinVIRELLA, G; MUNOZ, J. F; GALBRAITH, G. M. P et al.Clinical immunology and immunopathology (Print). 1995, Vol 75, Num 2, pp 179-189, issn 0090-1229Article

Enhancement of platelet aggregation by low-density lipoproteins from IDDM patientsWATANABE, J; WOHLTMANN, H. J; KLEIN, R. L et al.Diabetes (New York, NY). 1988, Vol 37, Num 12, pp 1652-1657, issn 0012-1797Article